MEDEC expects new, progressive policy on e-labelling
This article was originally published in RAJ Devices
The Canadian medical device industry association, MEDEC, is hopeful that Health Canada will take a more "progressive and flexible stance" on the issue of e-labelling as most major markets are already moving ahead with the concept in their respective jurisdictions. MEDEC expects the Canadian regulator to address the issue through a policy notice later this year1.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.